Bausch Health Companies | VRX - Trade Creditors


Bausch Health Companies reported $593M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Amgen USD 2.86B 16.65B Jun/2026
ANI Pharmaceuticals USD 69.69M 7.11M Mar/2026
Aurora Cannabis CAD 9.31M 58.72M Mar/2026
Bausch Health Companies USD 593M 0 Jun/2026
Biogen USD 403.9M 45.4M Jun/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Canopy Growth CAD 34.82M 14.85M Mar/2026
Corcept Therapeutics USD 14.91M 18.4M Jun/2026
Danaher USD 2.07B 282M Jun/2026
Drreddys Laboratories INR 22.36B 21.91B Mar/2026
Eli Lilly USD 6.11B 1.08B Jun/2026
Gilead Sciences USD 645M 70M Mar/2026
Nektar Therapeutics USD 10.03M 744K Mar/2026
Novo Nordisk DKK 14.59B 212M Jun/2026
Pacira USD 17.51M 3.5M Jun/2026
Perrigo USD 400.4M 34.4M Jun/2026
Phibro Animal Health USD 129.64M 3.65M Mar/2026
Prestige Brands USD 36.85M 14.06M Jun/2026
Supernus Pharmaceuticals USD 5.59M 4.58M Jun/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026
Zoetis USD 452M 55M Jun/2026